Wishing All The Best For The Coming Christmas And New Year 2023 Festive Season

BREAKING NEWS
News
Latests Medical News from around the world and also Thailand, bringing you updates, discoveries, studies and findings on various aspects and diseases in the medical world. Most of these articles are not only meant for Doctors In Thailand or Hospitals In Thailand but also for any patients or health conscious individuals wanting to know more.
Source: Rutgers University  Feb 24, 2019  4 years ago
A Rutgers study has found that a specific gene in cancerous prostate tumors indicates when patients are at high-risk for the cancer to spread, suggesting that targeting this gene can help patients live longer. The study, which was published in the journal Nature Communications, identified the NSD2 gene through a computer algorithm developed to determine which cancergenes that spread in a&nb...
Source: Vanderbilt University  Feb 23, 2019  4 years ago
Verticilide, an extract from the genus of fungus Verticillium, commonly found on plants and insects, is a promising compound to treat arrhythmia according to a research from a collaboration between Vanderbilt University professors of chemistry and medicine. Jeffrey Johnston, Stevenson Professor of Chemistry, said the natural product isn't active except in insects, but the synthetic mirror-i...
Source: University of California - Riverside  Feb 22, 2019  4 years ago
Multiple sclerosis is an autoimmune disease that affects more than 2.3 million people worldwide. This debilitating condition periodically shutters communication between the brain and other parts of the body, resulting in symptoms that range from numbness and tingling in the arms and legs to blindness and paralysis. While treatments are available to alleviate inflammation, no therapies exist to pro...
Source: Thailand Medical News  Feb 21, 2019  4 years ago
Doctors In Thailand practicing primary care medicine in 2019 have likely met this familiar greeting from a patient: “I Googled my symptoms and I think the problem is [insert condition].” Obviously, this can be unsettling for many providers – doctors in the past were often the first point of reference for patients who otherwise had no way of researching their health concerns on th...
Source: San Diego School Of Medicine  Feb 20, 2019  4 years ago
Proton pump inhibitors (PPIs), which include well-known brand names Prilosec, Miracid, Nexium and Prevacid, are among the most commonly prescribed medications in the world. Approximately 10 percent of adults in the United States take these drugs for frequent heartburn, acid reflux and gastroesophageal reflux disease. Given their prevalence, researchers at Skaggs School of Pharmacy and Pharmaceutic...
Source: University Of Melbourne  Feb 19, 2019  4 years ago
Scientists from the University Of Melbourne said  on Monday that they had discovered immune cells that can fight all known flu viruses in what was hailed as an "extraordinary breakthrough" that could lead to a universal, one-shot vaccine against the killer disease. Influenza epidemics, largely seasonal, kill hundreds of thousands of people each year, according to the World Health ...
Source: Dana-Farber Cancer Institute  Feb 18, 2019  4 years ago
A combination of two drugs -- one of them an immunotherapy agent -- could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial. Patients who received the immunotherapy drug avelumab plus axitinib, a targeted agent, had a significant advantage in progression-...
Source: NRG Oncology, Pennsylvania  Feb 17, 2019  4 years ago
The NRG Oncology clinical study NRG-RTOG 0415 determined that a hypofractionated radiotherapy schedule (H-RT), a treatment schedule that delivers a total dose of radiotherapy over a shorter period of time, is not worse than the conventional radiotherapy schedule (C-RT) in terms of bowel, bladder, sexual, and general quality of life (QOL) as well as anxiety and depression for men with low risk pros...
Thailand Medical News  Feb 16, 2019  4 years ago
Twelve patients who tried injections of stem cells were hospitalized with infections, according to a report in the New York Times that should cause patients concern. More important is that they should investigate stem cell treatments, for conditions such as cartilage injuries to their joints, before committing to one of these procedures. It's also a valuable reminder that physic...
Source: University of Exeter  Feb 16, 2019  4 years ago
Scientists have discovered new ways in which the body regulates blood clots, in a discovery which could one day lead to the development of better treatments that could help prevent and treat conditions including heart diseases, stroke and vascular dementia.   Led by the University of Exeter and funded by the British Heart Foundation, the team has developed a new technique  that allows ...
Source: University of Virginia  Feb 15, 2019  4 years ago
An antidepressant drug used to treat obsessive-compulsive disorder could save people from deadly sepsis, new research from the University of Virginia School of Medicine suggests. Sepsis is a significant cause of death around the world. The federal Centers for Disease Control and Infection calls it "the body's extreme response to an infection." Essentially, the body's immune re...
Source: University of Leicester  Feb 14, 2019  4 years ago
Results from a phase II clinical trial, experimental work on cells and computational modelling have together shown why the first pill for asthma in 20 years can help reduce asthma attacks. Researchers from Leicester (UK) and Vancouver (Canada) have shown that the investigational drug, Fevipiprant (an oral, selective prostaglandin D2 receptor antagonist), reduces the amount of smooth muscle in t...
Source: University of Cambridge/ University of Leicester  Feb 13, 2019  4 years ago
A blood test has been developed that could save countless lives by improving early detection of lung cancer. The test measures circulating DNA that is shed by cancer cells as they grow and multiply. Scientists believe it could predict the presence of low-grade tumours in the lungs long before they become a threat.   New research led by scientists at the Medical Research Council (MRC) Toxico...
Source: Stanford University School of Medicine  Feb 12, 2019  4 years ago
An antibody-based treatment can gently and effectively eliminate diseased blood-forming stem cells in the bone marrow to prepare for the transplantation of healthy stem cells, according to a study in mice by researchers at the Stanford University School of Medicine. The researchers believe the treatment could circumvent the need to use harsh, potentially life-threatening chemotherapy or radiati...
Source: Beth Israel Deaconess Medical Center  Feb 11, 2019  4 years ago
Lightheadedness with standing, otherwise known as postural lightheadedness, results from a gravitational drop in blood pressure and is common among adults. While mild in many adults, it has been cited as an important contributing factor in some harmful clinical events, such as falls. As a result, greater sodium intake is widely viewed as an intervention for preventing lightheadedness when moving f...
Source: The Institute of Cancer Research, London  Feb 10, 2019  4 years ago
A brand new type of cancer drug that acts as a ‘Trojan horse’ to get inside tumour cells has shown promise in patients with six different cancer types. In patients with advanced, drug-resistant cancers, over a quarter with cervical and bladder tumours, and nearly 15 per cent with ovarian and lung tumours, responded to the new treatment. The innovative new drug, called tisotumab ved...
Source: Duke University Medical Center  Feb 09, 2019  4 years ago
The use of MRI to determine heart function has been slow to catch on, but a study from Duke Health researchers shows that stress cardiac MRI not only diagnoses disease, but can also predict which cases are potentially fatal. Results from a large, multi-center study suggest that cardiac magnetic resonance, or CMR, has potential as a non-invasive, non-toxic alternative to stress echocardiograms, ...
Source: Massachusetts Institute of Technology  Feb 08, 2019  4 years ago
An MIT-led research team has developed a drug capsule that could be used to deliver oral doses of insulin, potentially replacing the injections that people with type 2 diabetes have to give themselves every day. An MIT-led research team has developed a drug capsule that could be used to deliver oral doses of insulin. Credit: Felice Frankel About the size of a blueberry, the capsule contains a...
Source: University Of Waterloo  Feb 07, 2019  4 years ago
Researchers at the University of Waterloo have developed a new way to prevent and treat Chlamydia, the most common sexually transmitted bacterial infection in the world. Chlamydia in a human cell. The new treatment differs from the traditional anti-biotic treatment as it is a type of gene therapy that is delivered via nanotechnology and is showing a 65 per cent success rate in preventing c...
Source: Cancer Research UK  Feb 06, 2019  4 years ago
Mutations that cause esophageal adenocarcinoma (OAC) have been mapped in unprecedented detail -- unveiling that more than half could be targeted by drugs currently in trials for other cancer types. This research, published  in Nature Genetics, could help stratify esophageal cancer patients to give them more personalised therapies. This could provide options not currently available to ...
Source: McGill University  Feb 05, 2019  4 years ago
Two new papers, published simultaneously in Nature Communications and led by researchers at McGill University, offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer, one rare and one common form.     The breakthrough discovery launching this research came in 2014 when Dr. William Foulkes, ...
Source: University of Texas Health Science Center at San Antonio  Feb 04, 2019  4 years ago
In long-term survivors of childhood cancer, cardiovascular disease is a leading cause of early death from non-cancer causes. In a new study, published in JAMA Oncology, researchers compared four chemotherapy drugs with development of cardiomyopathy (abnormal heart muscle with impaired function) years after treatment.     "Exposure to anthracycline chemotherapies, such ...
Source: Universitat Polytechnica de Valencia (UPV),Spain  Feb 03, 2019  4 years ago
Autoimmune diseases, such as systemic lupus erythematosus or rheumatoid arthritis, are difficult to diagnose, specially in early stages. Specifically, in the case of lupus, specific antibodies aimed at antigens located in the nucleus of cells appear, including the anti-Ro/SSA. These anti-Ro/SSA antibodies can be found in the blood before other autoantibodies related with lupus, and can even be det...
Source: Duke University Medical Center  Feb 02, 2019  4 years ago
A Duke Health pilot project suggests that in the near future, a blood test could show whether arteries carrying blood to the heart are narrow or blocked, a risk factor for heart disease. According to the 40-person study published in the journal PLOS ONE, emergency patients who underwent a treadmill stress test and showed signs of decreased blood flow to the heart also had changes in five met...
Source: University of San Diego  Feb 01, 2019  4 years ago
Search for a description of "p53" and it becomes clear that this human protein is widely known for its cancer-fighting benefits, leading to its renown as "the guardian of the genome." Scientists at the University of California San Diego have published a new study challenging that description. Studying the "wild type" version of p53 (WTp53), the form that exists b...
Source: Howard Hughes Medical Institute  Jan 31, 2019  4 years ago
Researchers can now quickly and accurately count a hidden, inactive form of the human immunodeficiency virus (HIV) that lurks in patients' cells. This version of HIV embeds into cells' genomes and can persist despite otherwise successful therapies, thwarting attempts to cure the infection. Using a new genetic technique developed by Howard Hughes Medical Institute Investigator Robert Sil...
Thailand Medical News  Jan 30, 2019  4 years ago
An often-overlooked type of STD, oral gonorrhea presents a challenge for healthcare in Thailand and globally. The threat this bacterial infection poses is not limited to the disease itself – there are large-scale public health issues related both to long-term inflammation by an infection in the throat or mouth left untreated and to the wrongful prescription of certain antibiotics that give r...
Source: Purdue University  Jan 29, 2019  4 years ago
Researchers have been struggling for years to find a treatment for patients who have a recurrence of acute myeloid leukemia (AML), an aggressive blood cancer that is one of the most lethal cancers. About 19,520 news cases are diagnosed a year, and about 10,670 people a year die from it, according to the American Cancer Society. Purdue University researchers are developing a series of drug compo...
Source: University of California - San Diego  Jan 28, 2019  4 years ago
A team of researchers led by the University of California San Diego has identified a genetic pathway that causes some individuals to develop an abnormal heart rhythm, or arrhythmia, after experiencing a heart attack. They have also identified a drug candidate that can block this pathway. "We now know one reason why a significant fraction of the public could develop secondary complications p...
Source: Thailand Medical News  Jan 28, 2019  4 years ago
In recent years, various agencies within the Thai government have made concerted efforts to curb private medical institutions’ independence by installing burdensome regulations -- most recently by seeking to control what these businesses can charge for specific medicines, procedures, and supplies. Their basic rationale is that cost controls and other measures are necessary to ensure the best...
Source: University of California, San Francisco  Jan 28, 2019  4 years ago
Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UC San Francisco has found. Non-steroidal anti-inflammatory drugs, or NSAIDs, improved the overall five-year survival rate from 25 percent to 78 percent for patients whose cancer contained a specific...
Source: Brigham and Women's Hospital  Jan 27, 2019  4 years ago
BRCA1 and BRCA2 ("BReast CAncer genes") are critical tumor suppressor genes—women carrying a mutation in one of these genes have up to an 80 percent risk of developing breast cancer and a 50 percent risk of developing ovarian cancer. Cancer drugs known as Parp inhibitors have recently been approved for treating patients with BRCA-driven metastatic breast cancer or recurrent ovarian...
Source: Thailand Medical News  Jan 26, 2019  4 years ago
The Thai conglomerate, Charoen Pokphand Group is one of the world’s largest. It is also Thailand’s largest private company. With investments in over 30 countries and a huge presence in the Chinese market the group employs over 350,000 staff. It’s 3 core businesses operate in: Agribusiness & Food Retail & Distribution Telecommunications industries So, it was with sur...
Source: Liverpool School of Tropical Medicine  Jan 26, 2019  4 years ago
Researchers at LSTM and Imperial College London have designed drugs which could help combat any potential new flu pandemic, by targeting the receptors of the cells by which the virus gains entry to the human body. In a paper published  in the Journal of Immunology the team, led by LSTM's Professor Richard Pleass, show that by engineering a part of an antibody they can target ...
Source: Pediatric Hematology and Oncology Dept, Hospital Sant Joan de Deu, Barcelona   Jan 25, 2019  4 years ago
A European team of researchers reports that modifying an adenovirus a certain way made it an effective tumor killer in mice with retinoblastoma. In their paper published in the journal Science Translational Medicine, the researchers describe modifying the virus and testing its effectiveness in treating retinoblastoma. Retinoblastoma, as its name implies, is a cancer of the retina. It is mos...
Source: Cortexyme, Inc, US  Jan 24, 2019  4 years ago
Cortexyme, Inc., a privately held, clinical-stage pharmaceutical company developing therapeutics to alter the course of Alzheimer's disease (AD) and other degenerative disorders, today announced publication of a foundational paper supporting its approach in Science Advances. In the paper, an international team of researchers led by Cortexyme co-founders Stephen Dominy, M.D. and Casey Lync...
Source: NYU Langone Health, New York  Jan 23, 2019  4 years ago
Most studies evaluating platelet-rich plasma (PRP) injection for facial rejuvenation and other cosmetic procedures have reported positive results, according to a critical review in the publication: Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS). PRP Injections are reportedly the latests trends of 2019 for Aesthetic Clinics a...
Source: Medical College of Georgia at Augusta University  Jan 23, 2019  4 years ago
Lingering inflammation in the colon is a known risk factor for colorectal cancer and now scientists report one way it resets the stage to enable this common and often deadly cancer. Inflammation is supposed to be a short-term response to an infection or other irritant in the body that is essential to eliminating it. But when inflammation persists, it can contribute to a myriad of common condit...
Source: University of Pennsylvania  Jan 22, 2019  4 years ago
Immune cells called macrophages are supposed to serve and protect, but cancer has found ways to put them to sleep. Now researchers at the Abramson Cancer Center of the University of Pennsylvania say they've identified how to fuel macrophages with the energy needed to attack and eat cancer cells. It is well established that macrophages can either support cancer cell growth and spread or hinder ...
Source: Flinders University  Jan 21, 2019  4 years ago
A new antibiotic developed by a Flinders University researcher is being heralded as a breakthrough in the war against a drug resistant superbug. Bacteria are winning the fight against antibiotics as they evolve to fight off traditional treatments, threatening decades of advancements in modern medicine, with predictions they will kill over 10 million people by 2050. The scientific development o...
Source: Netherlands Institute for Neuroscience - KNAW  Jan 20, 2019  4 years ago
Researchers from the Netherlands Institute for Neuroscience (NIN) and the Leiden University Medical Center (LUMC) have shown that treatment using gene therapy leads to a faster recovery after nerve damage. By combining a surgical repair procedure with gene therapy, the survival of nerve cells and regeneration of nerve fibers over a long distance was stimulated for the first time. The discovery, pu...
Source: Hong Kong Baptist University  Jan 19, 2019  4 years ago
Epstein-Barr virus infects more than 95 percent of people, usually without symptoms. But sometimes its persistence in cells can lead to tumor formation. Now, researchers from Hong Kong and the UK have developed a fluorescing, molecular-sized probe, called L2P4, which can inhibit Epstein-Barr-related tumor growth while allowing researchers to see the targeted tumor cells. Epstein-Barr v...
Source: US FDA  Jan 18, 2019  4 years ago
The Food and Drug Administration (FDA) has issued a safety alert regarding the possibility of an increased risk of death associated with the use of paclitaxel-coated balloons and paclitaxel-eluting stents for the treatment of peripheral arterial disease (PAD). The FDA's communication follows a recent meta-analysis published in the Journal of the American Heart Association ...
Thailand Medical News  Jan 18, 2019  4 years ago
Various research reports on Thailand’s role in the production, local dissemination and exportation to domestic as well as international markets for medical devices reveal healthy forecasts. Predications are that the medical device market in the country  will continue to grow at average rates of between 8.5-10% per annum. Such strength in growth opens exciting opportunities for the Me...
Source: Washington University School of Medicine , St. Louis   Jan 18, 2019  4 years ago
Scientists working to develop more effective treatments for diabetes are turning to stem cells. Such cells can be transformed into cells that produce insulin, the hormone that controls blood sugar. Researchers at Washington University School of Medicine in St. Louis have tweaked the recipe for coaxing human stem cells into insulin-secreting beta cells and shown that the resulting cells are more ...
Source: NYU Langone Health / NYU School of Medicine  Jan 17, 2019  4 years ago
A new class of engineered proteins may counter infection caused by Staphylococcus aureus -- a bacterial species considered one of the largest global health threats, a new study suggests. Published online Jan. 16 in Science Translational Medicine, the study is the result of a five-year research partnership between scientists at NYU School of Medicine and Janssen Research & Dev...
Source: Hong Kong University  Jan 16, 2019  4 years ago
The world has been repeatedly plagued by infectious disease outbreaks, including SARS and MERS coronaviruses, avian influenza viruses, and Zika virus. A team at the Medical Faculty of The University of Hong Kong (HKUMed) led by Professor Yuen Kwok-yung and Dr Shuofeng Yuan of the Department of Microbiology, has discovered a novel broad-spectrum antiviral drug that would be strategic for epidemic c...
Thailand Medical News  Jan 16, 2019  4 years ago
The bacterium Mycoplasma genitalium (MG) is sexually transmitted and can cause inflammation of the urinary and genital tracts in men and women. This germ may also be linked to other problems, including some cases of arthritis and, in women, pelvic inflammatory disease and infertility. MG appears to be spread by unprotected anal or vaginal intercourse, as it can be detected in fluid s...
Source: PLOS  Jan 15, 2019  4 years ago
A practical resource-based public health approach for the rapid initiation of antiretroviral therapy in HIV-infected individuals living in low- and middle-income countries could save thousands of lives, according to an Essay published January 15 in the open-access journal PLOS Medicine by Mark Tenforde of the University of Washington School of Medicine, and colleagues. Effective antir...
Source: Hyogo College of Medicine, Japan  Jan 15, 2019  4 years ago
In a recent study conducted by Professor Dr. Tadayuki Oshima and Professor Dr. Eitatsu Arai from Hyogo College of Medicine, in Japan , demonstrated that the potassium-competitive acid blocker (P-CAB) vonoprazan demonstrates superior efficacy in the treatment of patients with erosive oesophagitis compared with the proton pump inhibitor (PPI) lansoprazole, with the results of a small ...
Source: North American Menopause Society (NAMS).  Jan 14, 2019  4 years ago
There is an ongoing debate regarding the relationship between knee osteoarthritis and hormone therapy (HT), with small-scale studies providing mixed results. A new large-scale study from Korea shows that women receiving HT had a significantly lower prevalence of symptomatic knee osteoarthritis compared with women who did not take hormones. Study results are published online in Menopause, the ...
Source: VIB (the Flanders Institute for Biotechnology)  Jan 13, 2019  4 years ago
Spondyloarthritis is one of the most common types of chronic joint inflammation affecting nearly 1-2% of the Western population. Cytokine blockade of Tumor necrosis factor (TNF) and more recently Interleukin-17 (IL-17) has revolutionized the perspectives of patients suffering from this disease by achieving high levels of therapeutic efficacy. The disease differs substantially from rheumatoid arthr...
Source: Loyola University Health System  Jan 12, 2019  4 years ago
A landmark study co-authored by a Loyola Medicine oncologist has found that a newer targeted drug is significantly more effective than standard therapy for treating elderly patients with chronic lymphocytic leukemia (CLL). The drug, ibrutinib, attacks cancer cells without damaging normal cells, thus causing fewer side effects. The drug is taken as a pill once a day -- much more convenient than ...
Source: University Of Basel  Jan 11, 2019  4 years ago
The most deadly aspect of breast cancer is metastasis. It spreads cancer cells throughout the body. Researchers at the University and the University Hospital of Basel have now discovered a substance that suppresses the formation of metastases. In the journal Cell, the team of molecular biologists, computational biologists, and clinicians reports on their interdisciplinary approach. The ima...
Source: Johns Hopkins University School of Medicine  Jan 10, 2019  4 years ago
New research from Johns Hopkins Medicine and Sheppard Pratt Health System shows that people in the study with schizophrenia also have higher levels of antibodies against the Epstein-Barr virus (EBV), a herpes virus that causes infectious mononucleosis, so-called mono. Researchers proposed two explanations for the association of heightened immune responses in patients with schizophrenia and EBV in...

MOST READ

Sep 08, 2022  3 months ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 13, 2020  2 years ago
Source: Supplements For COVID-19
Feb 05, 2020  3 years ago
Source : Thailand Medical news

Interesting Reads

Source: COVID-19 Convalescent Plasma and Hyperimmune Plasma Or H-Ig Therapies
Jun 15, 2020  2 years ago
Source: Nitric Oxide and COVID-19
Jun 15, 2020  2 years ago
Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020  2 years ago
Source: COVID-19 Long-Term Health Implications
Jun 13, 2020  3 years ago
Source: COVID-19, Influenza and Next Wave
Jun 10, 2020  3 years ago
Source: Myocardial Injury
Jun 09, 2020  3 years ago
Source: COVID-19 News
May 21, 2020  3 years ago
Source: Covid-19 Treatments And Drugs News
Mar 20, 2020  3 years ago
Source: SARS-Cov-2 Coronavirus Research
Mar 08, 2020  3 years ago
Source : Thailand Medical News
Feb 11, 2020  3 years ago